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Different crystal forms diffracting to high resolution have been
obtained for two NADP(H)-dependent alcohol dehydrogenases,
members of the medium-chain dehydrogenase/reductase superfamily:
ScADHVI from Saccharomyces cerevisiae and ADH8 from Rana
perezi. ScADHVI is a broad-speci®city enzyme, with a sequence
identity lower than 25% with respect to all other ADHs of known
structure. The best crystals of ScADHVI diffracted beyond 2.8 AÊ
resolution and belonged to the trigonal space group P3121 (or to its
enantiomorph P3221), with unit-cell parameters a = b = 102.2,
c = 149.7 AÊ ,  = 120. These crystals were produced by the hanging-
drop vapour-diffusion method using ammonium sulfate as precipi-
tant. Packing considerations together with the self-rotation function
and the native Patterson map seem to indicate the presence of only
one subunit per asymmetric unit, with a volume solvent content of
about 80%. ADH8 from R. perezi is the only NADP(H)-dependent
ADH from vertebrates characterized to date. Crystals of ADH8
obtained both in the absence and in the presence of NADP+ using
polyethylene glycol and lithium sulfate as precipitants diffracted to
2.2 and 1.8 AÊ , respectively, using synchrotron radiation. These
crystals were isomorphous, space group C2, with approximate unit-
cell parameters a = 122, b = 79, c = 91 AÊ ,  = 113 and contain one
dimer per asymmetric unit, with a volume solvent content of about
50%.
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1. Introduction
Most alcohol dehydrogenases (ADHs) of wide
substrate speci®city from yeast and vertebrates
are members of the medium-chain dehydro-
genase/reductase (MDR) superfamily, which
has been divided into different enzyme families
with regard to structural and functional rela-
tionships (JoÈ rnvall et al., 2001).
The classical S. cerevisiae ADHs involved in
alcohol production and assimilation are tetra-
meric enzymes structurally related to verte-
brate ADHs (Ciriacy, 1997). We have recently
reported the characterization of a new yeast
ADH, named ADHVI, presumably a dimer of
molecular weight 80 kDa, with only 26%
sequence identity to the tetrameric enzyme
family (Larroy et al., 2002). Primary structure
analysis shows that ADHVI belongs to a
different family within the MDRs, the
cinnamyl alcohol dehydrogenases (CADs; 37%
identity). Consistent with this, ADHVI uses
NADP(H) as a cofactor, exhibits a broad
substrate speci®city with aromatic and linear
hydrophobic alcohols and shows high activity
towards cinnamyl alcohol and cinnamyl alde-
hyde. In plants, CAD enzymes participate in
the synthesis of cinnamyl alcohol derivatives in
the last steps of lignin biosynthesis (Luderitz &
Grisebach, 1981). Since S. cerevisiae does not
synthesize lignin, we hypothesized that the
yeast ADHVI could contribute to lignin
degradation and the last step of the synthesis of
fusel alcohols derived from amino-acid and
-ketoacid metabolism (Larroy et al., 2002). No
crystallographic structure has been reported
for any member of the CAD family. The closest
known structures to ADHVI (25% identity)
are of a NADP(H)-dependent ketose reduc-
tase from the white¯y Bemisia argentifolii
(Ban®eld et al., 2001) and human ADH4 (Xie
et al., 1997).
In vertebrates, ADHs constitute a family of
eight different classes involved in ethanol
metabolism and also in the transformation of a
variety of alcohols and aldehydes of physio-
logical importance, such as retinoids, steroids
and cytotoxic aldehydes (Duester et al., 1999).
All ADHs from vertebrates are dimers of
about 80 kDa and contain two Zn atoms per
subunit. In mammals, ADH1 and ADH4 have
been the most studied classes because of their
wide expression level in tissue and their
activity towards ethanol and retinol (Boleda et
al., 1993). The oxidation of retinol to retinal is
the initial step in the synthesis of retinoic acid,
an important modulator of gene expression.
While ADH1 is present in all vertebrate
Acta Cryst. (2003). D59, 334±337 Valencia et al.  NADP(H)-dependent alcohol dehydrogenases 335
crystallization papers
groups, ADH4 has only been described in
mammals. In our search for an ADH4-type
enzyme in amphibians, we found an enzyme
with similar kinetic properties to those of
ADH4 but, surprisingly, with speci®city
towards NADP(H) instead of NAD(H), the
common coenzyme for all previously
described vertebrate ADHs. This enzyme
(ADH8) was isolated from the stomach of
R. perezi and exhibited high activity towards
retinal (Peralba et al., 1999). In consequence,
we proposed a physiological function in
retinal reduction for ADH8, which is also
supported by the high cellular NADPH:
NADP+ ratio.
Several crystallographic structures of
vertebrate ADHs are known: horse ADH1
(Eklund et al., 1976), human ADH1B1,
ADH1B2 and ADH1B3 (Hurley et al.,
1994), human ADH1A and ADH1C2
(Niederhut et al., 2001), cod ADH1
(Ramaswamy et al., 1996), mouse ADH2
(Svensson et al., 2000), human ADH3 (Yang
et al., 1997) and human ADH4 (Xie et al.,
1997). All of them correspond to NAD(H)-
dependent enzymes and exhibit less than
57% identity with the present amphibian
ADH8. Crystallization and structure deter-
mination of ADH8 would provide the basis
for the unique cofactor speci®city of this
enzyme and for its particularly high activity
towards retinal.
In the present report, we describe the
crystallization and the crystal properties of
two ADHs from the MDR superfamily:
S. cerevisiae ADHVI, an NADP(H)-
dependent ADH and the ®rst member
crystallized of the CAD family, and amphi-
bian ADH8, the ®rst NADP(H)-dependent
ADH member of the vertebrate ADH
family.
2. Experimental results
2.1. Crystallization, data collection and
X-ray analysis
2.1.1. NADP(H)-dependent ADHVI from
S. cerevisiae (ScADHVI). ScADHVI was
obtained from yeast cells by a modi®cation
of a previously described protocol (Larroy et
al., 2002). The modi®cation consisted of
performing the DEAE-Sepharose chroma-
tography at pH 8.0 instead of pH 7.0, which
resulted in increased purity and allowed
bypassing of the hydroxyapatite column.
Pure enzyme was used in crystallization
screening using the hanging-drop vapour-
diffusion method. 1 ml drops of concentrated
sample (6 mg mlÿ1) were mixed with the
same volume of a reservoir solution
containing 2 M ammonium sulfate (AS) and
equilibrated at 293 K against a reservoir
volume of 1 ml. Well developed bipyramidal
hexagonal crystals reaching 0.4  0.4 
0.6 mm in size appeared in 2 d (Fig. 1).
These crystals belong to space group P3121
(or to its enantiomorph P3221), with unit-
cell parameters a = b = 102.2, c = 149.7 AÊ ,
 = 120). An X-ray diffraction data set was
collected using synchrotron radiation and a
MAR CCD detector at ESRF (Grenoble,
France) at 100 K with 20%(v/v) glycerol as
cryoprotectant. Data were processed and
scaled with the programs DENZO and
SCALEPACK (Otwinowski & Minor,
1996), respectively, giving an overall Rmerge
of 7.7% and a completeness of 99% at 2.8 AÊ
(Table 1). An X-ray ¯uorescence scan of one
of the crystals (performed on beamline
BM14) showed a clear absorption edge with
the peak at 9671.4 eV, strongly supporting
the existence of Zn ions in ScADHVI (Kim
& Howard, 2002).
Packing considerations indicate that,
assuming a protein-subunit molecular
weight of about 40 kDa, these crystals could
contain one, two or three subunits per
asymmetric unit, with corresponding volume
solvent contents ranging from 80 to 42%
(Matthews, 1968). In turn, the absence of
signi®cant peaks in both the native
Patterson map and in the self-rotation
function (Fig. 2) makes the existence of
non-crystallographic symmetry unlikely,
although molecular twofold axes oriented
almost parallel to the crystallographic
twofold axis are still possible. The weakness
of the diffraction at high resolution despite
the good morphology and size of the
ScADHVI crystals could also be related to a
high solvent content. Even if these crystals
contain only one subunit per asymmetric
unit, the ScADHVI molecules could be
homodimers as suggested by Larroy et al.
(2002) if the molecular and crystallographic
twofold axes coincide.
No solution has yet been obtained by
molecular replacement with the programs
AMoRe (Navaza, 1994) and BEAST (Read,
2001) using search models derived from
human ADH1B1 (Hurley et al., 1991),
human ADH4 (Xie et al., 1997), horse
ADH1 (Adolph et al., 2000) and ketose
reductase (Ban®eld et al., 2001) and from
combinations of the N-terminal catalytic and
coenzyme-binding domains of these struc-
tures. All ADH molecules used as search
models exhibit sequence identities with
ScADHVI of below 25% which, together
Figure 1
Crystals of (a) ScADHVI and (b) ADH8. Despite the
size and good morphology of the ScADHVI crystals,
diffraction was extremely weak beyond approxi-
mately 2.8 AÊ resolution, which may be related to
the high solvent content.
Table 1
Data-collection statistics.
Values in parentheses refer to the outer shell.
ADH8 ADH8 (NADP+) ScADHVI
Space group C2 C2 P3121 or P3221
Unit-cell parameters (AÊ , ) a = 122.5, b = 79.5,
c = 91.9,  = 113.1
a = 122.2, b = 79.5,
c = 91.8,  = 112.8
a = b = 102.2,
c = 149.7,  = 120
No. measured re¯ections 150436 254342 120598
No. unique re¯ections 79197 140960 22735
Resolution (AÊ ) 2.20 (2.28±2.20) 1.80 (1.86±1.80) 2.80 (2.90±2.80)
Rmerge² (%) 11.3 (44.7) 4.8 (33.1) 7.7 (40.0)
Completeness (%) 98.4 (99.0) 96.1 (74.2) 99.8 (99.8)
hI/(I)i 11.8 (2.6) 14.4 (1.6) 24.3 (2.2)
Mosaicity () 0.4 0.4 0.2
² Rmerge =
P jIi ÿ hIij=P Ii , where Ii is the measured intensity of an individual re¯ection and hIi is the average intensity of the
symmetry-related measurements of this re¯ection.
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with the dif®culties in ®nding a molecular-
replacement solution, suggests signi®cant
structural differences. Searches for heavy-
atom derivatives and MAD experiments at
the Zn edge are now under way.
2.1.2. NADP(H)-dependent ADH from
R. perezi (ADH8). Wild-type ADH8 cDNA
was obtained from isolated poly(A)+ RNA
and cloned into pBluescript II SK (+)
(Peralba et al., 1999). Cloning into pGEX
4T-2 (Amersham Pharmacia Biotech) was
performed by ampli®cation of the coding
region using the polymerase chain reaction
(PCR) with two speci®c primers, RanaL (50-
TTATAGGATCCATGTGCACTGCGGG-
AAAAGAT-30) and RanaR (50-CCAC-
CTGAATTCTTAGTATATCATAATGCT-
TCG-30), including restriction sites (bold)
for BamHI and EcoRI, respectively. The
resulting PCR product was puri®ed by
means of the Concert Rapid Gel Extraction
System (Life Technologies) and then cloned
into the BamHI and EcoRI sites of pGEX
4T-2. Escherichia coli BL21 competent cells
were transformed with the construct.
Expression and batchwise puri®cation
were carried out by means of the GST Gene
Fusion System (Amersham Pharmacia
Biotech). Wild-type cDNA was expressed
by inoculating 2YT liquid medium,
containing 75 mg mlÿ1 ampicillin, with an
overnight culture (1:100 dilution) of BL21
cells containing the pGEX 4T-2 harbouring
the ADH8 cDNA. Cells were grown at
276 K until an absorbance of 0.8±1.0 at
600 nm was reached. Isopropyl -d-thio-
galactoside was then added to a ®nal
concentration of 0.1 mM. Bacteria were
incubated for 15 h at 296 K and then
harvested by centrifugation and stored at
193 K. The pellet was resuspended (100 ml
per litre of culture) in cold phosphate-
buffered saline (1PBS; 1.8 mM KH2PO4,
10 mM NaH2PO4, 140 mM NaCl, 2.7 mM
KCl pH 7.3) containing 2.5 mM dithio-
threitol (DTT). Cells were treated with a
1 mg mlÿ1 ®nal concentration of lysozyme
for 30 min at 277 K, sonicated, incubated
with bovine DNAse for 30 min at 277 K and
®nally treated with 1%(v/v) Triton X-100 for
30 min at 277 K to aid in solubilization of the
fusion protein. Cell debris was separated by
centrifugation at 12 000g for 15 min at
277 K.
A batchwise puri®cation of the fusion
protein was carried out by incubation of the
cleared cell lysate with glutathione
Sepharose 4B (2 ml 50% matrix per litre of
culture) at room temperature for 90 min
with gentle agitation. The suspension was
centrifuged at 500g for 5 min at 277 K and
the supernatant was discarded. The matrix
containing bound protein was washed three
times with 1PBS by gentle agitation. All
centrifugations for washing and elution were
performed as described above. Fusion
protein bound to matrix was cleaved with
thrombin (50 U per litre of culture) by
agitation for 15 h at room temperature.
Following incubation, the suspension was
centrifuged to pellet Sepharose beads. The
GST portion of the fusion protein remained
bound to the matrix, while the eluate
contained ADH8. The puri®cation buffer
was exchanged using Centricon Plus-20
(Millipore) to 10 mM sodium phosphate/
NaOH pH 6.5 containing 2.5 mM DTT. The
protein was then further concentrated and
stored at 193 K. The fraction containing
ADH activity was subjected to an additional
af®nity chromatography step in Red
Sepharose CL-6B (Amersham Pharmacia
Biotech) to eliminate thrombin. This puri®-
cation was performed in batches as
described above, but ADH8 was eluted
in the presence of 0.6 M NaCl. This
fraction was subjected to SDS±PAGE and
Coomassie Blue staining to assess the degree
of purity.
Samples of ADH8 with an initial
protein concentration of 12 mg mlÿ1 (Brad-
ford, 1976) were used in crystallization
screening with the hanging-drop vapour-
diffusion method. Monoclinic crystals
belonging to space group C2 were obtained
in about a week using 20% PEG 4000 and
0.2 M LiSO4 as precipitants in 0.1 M Tris±
HCl pH 8 (Fig. 1). The size of the crystals
increased, reaching 0.2  0.2  0.3 mm,
when methanol was used as an additive.
Crystals with the same morphology and
about the same size were also obtained at
277 K under similar crystallization condi-
tions from ADH8 samples that had been
incubated overnight with 1 M NADP+
(Table 1).
Diffraction data were collected to 2.2 AÊ
using synchrotron radiation at ESRF
(Grenoble) from ADH8 crystals grown
without nucleotide and ¯ash-cooled to
liquid-nitrogen temperature. The cryobuffer
was prepared from the crystallization solu-
tion supplemented with glycerol to a ®nal
concentration of 25%(v/v) in three steps. In
a similar way, a diffraction data set to 1.8 AÊ
was collected from ADH8 crystals grown in
the presence of NADP+. Both data sets were
processed and scaled with the programs
DENZO and SCALEPACK (Otwinowski &
Minor, 1996), giving overall Rmerge values of
Figure 2
(a) Representation of the  = 180 (left) and  = 120 (right) sections containing the only signi®cant peaks found in the self-rotation function of the ScADHVI crystals, which
con®rm the 3m point-group symmetry. (b) Representation of the  = 180 section of the self-rotation function of ADH8 crystals. The largest peak, indicated I in the ®gure,
corresponds to the crystallographic twofold axis. The second peak (II in the ®gure) corresponds to the molecular twofold axis. All self-rotation calculations were performed
in the resolution range 20±3 AÊ with an integration radius of 30 AÊ .
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11.3 and 4.8 and completenesses of 98 and
96%, respectively (Table 1). These crystals
contain two protein subunits, corresponding
to one molecule, in the crystal asymmetric
unit, with the molecular twofold axis
approximately 10 from the crystallographic
twofold axis (Fig. 2). A clear molecular-
replacement solution, where the ®rst peak in
the rotation function was about twice the
intensity of the second, has been found using
the program AMoRe (Navaza, 1994) with a
search model derived from the structure of
human ADH1B1 (PDB code 1deh; Hurley et
al., 1991).
3. Conclusions
Different crystal forms diffracting to high
resolution have been obtained for two
NADP(H)-dependent alcohol dehydro-
genases: ScADHVI from S. cerevisiae and
ADH8 from R. perezi. ScADHVI is a broad-
speci®city ADH (Larroy et al., 2002), a
member of the CAD enzymatic family, with
a sequence identity lower than 25% with
respect to all other ADHs of known struc-
ture. No molecular-replacement solution has
yet been found, which suggests important
structural differences from the available
ADH structures. In turn, a preliminary
molecular-replacement solution has already
been found for ADH8, the only NADP(H)-
dependent ADH from vertebrates char-
acterized to date.
The structure determination at high
resolution of both ScADHVI and ADH8
would clarify the molecular peculiarities of
the NADP(H)-dependent ADHs, particu-
larly their cofactor preference. Moreover,
the ScADHVI structure would provide the
®rst three-dimensional approach to explain
the structure±function relationships in the
cinnamyl alcohol dehydrogenase family.
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